Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review

被引：0
|
作者：
Villa, Alessandro [1 ,2 ]
Schneider, Bryan J. [3 ]
Lacchetti, Christina [4 ]
Oliver, Thomas K. [4 ]
Peterson, Douglas E. [5 ]
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Oral Med Oral Oncol & Dent, Miami, FL 33143 USA
[2] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA 94115 USA
[3] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[4] Amer Soc Clin Oncol, Alexandria, VA USA
[5] UConn Hlth, Sch Dent Med, Farmington, CT USA
来源：
BRITISH JOURNAL OF CANCER | 2025年 / 132卷 / 01期
关键词：
D O I：
10.1038/s41416-024-02933-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [1] Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review
    Jayathilaka, Bishma
    Mian, Farah
    Franchini, Fanny
    Au-Yeung, George
    Ijzerman, Maarten
    BRITISH JOURNAL OF CANCER, 2025, 132 (01) : 51 - 57
  • [2] Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review
    Barron, Carly C.
    Stefanova, Isabella
    Cha, Yevin
    Elsolh, Karam
    Zereshkian, Arman
    Gaafour, Nessma
    McWhirter, Elaine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [3] Immune Related Adverse Events Associated with Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review of Case Reports
    Abdel-Wahab, Noha
    Suarez-Almazor, Maria E.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Immune-related adverse events of immune checkpoint inhibitors: a review
    Yin, Qinan
    Wu, Liuyun
    Han, Lizhu
    Zheng, Xingyue
    Tong, Rongsheng
    Li, Lian
    Bai, Lan
    Bian, Yuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors
    Lisa A. Kottschade
    Current Oncology Reports, 2018, 20
  • [6] Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors
    Kottschade, Lisa A.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (03)
  • [7] Neurologic Adverse Events of Immune Checkpoint Inhibitors A Systematic Review
    Marini, Alessandro
    Bernardini, Andrea
    Gigli, Gian Luigi
    Valente, Mariarosaria
    Muniz-Castrillo, Sergio
    Honnorat, Jerome
    Vogrig, Alberto
    NEUROLOGY, 2021, 96 (16) : 754 - 766
  • [8] The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review
    Machado, Antonio Pizuorno
    Ratliff, Hunter
    Abdelwahab, Ahmed
    Vohra, Muhammad H.
    Kuang, Andrew
    Shatila, Malek
    Khan, Muhammad Ali
    Shafi, Menhaz A.
    Thomas, Anusha S.
    Philpott, Jessica
    Alhalabi, Omar
    Wang, Yinghong
    JOURNAL OF CANCER, 2023, 14 (16): : 2956 - 2963
  • [9] Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors A Systematic Review
    Nadelmann, Emily R.
    Yeh, Jennifer E.
    Chen, Steven T.
    JAMA ONCOLOGY, 2022, 8 (01) : 130 - 138
  • [10] Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors
    Weinmann, Sophia C.
    Pisetsky, David S.
    RHEUMATOLOGY, 2019, 58 : 59 - 67
12345